Literature DB >> 25008255

Impact of baseline atrial fibrillation cycle length on acute and long-term outcome of persistent atrial fibrillation ablation.

S Ammar1, G Hessling, M Paulik, T Reents, R Dillier, A Buiatti, V Semmler, C Kolb, B Haller, I Deisenhofer.   

Abstract

BACKGROUND: A short baseline atrial fibrillation (AF) cycle length (CL) has been associated with a worse outcome after catheter ablation for AF, whereas the impact of a long baseline AFCL is unknown. We investigated the influence of AFCL on acute and long-term success in a large series of patients undergoing catheter ablation for persistent AF.
METHODS: Overall, 177 consecutive patients undergoing catheter ablation of persistent AF using a sequential ablation approach were included in the analysis. AFCL was measured in the left atrial appendage (LAA) at baseline and following each ablation step. The primary endpoint was freedom from any atrial arrhythmia off antiarrhythmic drugs (AAD) with a single ablation procedure after 12 months.
RESULTS: Mean AFCL was 164 ± 24 ms. A shorter AFCL was associated with longer AF duration, larger LA diameter, and longer procedure duration. Termination to sinus rhythm (SR) was achieved in 57 (32 %) patients. Baseline AFCL was shorter (161 ± 24 ms) in patients without AF termination compared to patients with AF termination (169 ± 23 m, p = 0.03). The primary endpoint was reached less frequently in patients with a short (<155 ms) AFCL (18 vs. 38.5 %, p = 0.006). Patients with an AFCL between 155 and 200 ms had the best outcome compared to patients with AFCL <155 or ≥200 ms (40 vs. 18 %, p = 0.003).
CONCLUSIONS: Patients with a baseline AFCL between 155 and 200 ms have the best outcome after a single ablation procedure for persistent AF compared to patients with an AFCL of <155 or ≥200 ms.

Entities:  

Mesh:

Year:  2014        PMID: 25008255     DOI: 10.1007/s10840-014-9927-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  26 in total

1.  Atrial fibrillatory cycle length: computer simulation and potential clinical importance.

Authors:  Michel Haissaguerre; Kang-Teng Lim; Vincent Jacquemet; Martin Rotter; Lam Dang; Mélèze Hocini; Seiichiro Matsuo; Sébastian Knecht; Pierre Jaïs; Nathalie Virag
Journal:  Europace       Date:  2007-11       Impact factor: 5.214

2.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

3.  Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis.

Authors:  F D'Ascenzo; A Corleto; G Biondi-Zoccai; M Anselmino; F Ferraris; L di Biase; A Natale; R J Hunter; R J Schilling; S Miyazaki; H Tada; K Aonuma; L Yenn-Jiang; H Tao; C Ma; D Packer; S Hammill; F Gaita
Journal:  Int J Cardiol       Date:  2012-05-22       Impact factor: 4.164

4.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.

Authors:  Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Rong Bai; Agnes Pump; Pasquale Santangeli; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-04-03       Impact factor: 24.094

5.  Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation.

Authors:  Sander Verheule; Els Tuyls; Arne van Hunnik; Marion Kuiper; Ulrich Schotten; Maurits Allessie
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-10-11

Review 6.  The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect.

Authors:  Mark D O'Neill; Pierre Jaïs; Yoshihide Takahashi; Anders Jönsson; Frédéric Sacher; Mélèze Hocini; Prashanthan Sanders; Thomas Rostock; Martin Rotter; Andrej Pernat; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Interv Card Electrophysiol       Date:  2006-11-14       Impact factor: 1.900

7.  Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium.

Authors:  K B Kim; M D Rodefeld; R B Schuessler; J L Cox; J P Boineau
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

8.  Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation.

Authors:  Sonia Ammar; Gabriele Hessling; Tilko Reents; Maria Paulik; Stephanie Fichtner; Patrick Schön; Roger Dillier; Susanne Kathan; Clemens Jilek; Christof Kolb; Bernhard Haller; Isabel Deisenhofer
Journal:  J Cardiovasc Electrophysiol       Date:  2012-12-17

9.  Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Li-Fern Hsu; Dipen C Shah; Christophe Scavée; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Stéphane Garrigue; Jacques Clémenty; Pierre Jaïs
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  2 in total

Review 1.  Catheter Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation.

Authors:  Martin Fiala
Journal:  J Atr Fibrillation       Date:  2016-10-31

2.  Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome.

Authors:  Marianna Meo; Thomas Pambrun; Nicolas Derval; Carole Dumas-Pomier; Stéphane Puyo; Josselin Duchâteau; Pierre Jaïs; Mélèze Hocini; Michel Haïssaguerre; Rémi Dubois
Journal:  Front Physiol       Date:  2018-07-17       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.